H-KIFGLSAFL-OH

Ref. 3D-PP46507

Información del producto

• Nombre: H-KIFGLSAFL-OH
• Sinónimos: NH2-Lys-Ile-Phe-Gly-Leu-Ser-Ala-Phe-Leu-OH

Descripción

Peptide H-KIFGLSAFL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-KIFGLSAFL-OH include the following: Can Patients with HER2-Low Breast Cancer Benefit from Anti-HER2 Therapies? A Review J Wang, D Liao, X Zhang, C Miao - Breast Cancer: Targets , 2023 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.2147/BCTT.S407181 Initial safety analysis of a randomized phase II trial of nelipepimut-S+ GM-CSF and trastuzumab compared to trastuzumab alone to prevent recurrence in breast cancer GT Clifton, KM Peace, JP Holmes, TJ Vreeland - Clinical , 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1521661618304637 Results of a randomized phase IIb trial of nelipepimut-S+ trastuzumab versus trastuzumab to prevent recurrences in patients with high-risk HER2 low-expressing GT Clifton, D Hale, TJ Vreeland , AT Hickerson - Clinical Cancer , 2020 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/26/11/2515/284527 Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ AE O'Shea, GT Clifton, N Qiao - Cancer Prevention , 2023 - AACRhttps://aacrjournals.org/cancerpreventionresearch/article-abstract/16/6/333/726436

• Marca: Biosynth